enVVeno Medical Corporation (NVNO) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
NVNO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NVNO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export NVNO earnings history in CSV or JSON format
Free sign-in required to download data
enVVeno Medical Corporation (NVNO) Earnings Overview
As of May 8, 2026, enVVeno Medical Corporation (NVNO) reported trailing twelve-month net income of -$19M, reflecting +97.9% year-over-year growth. The company earned $-28.77 per diluted share over the past four quarters.
Looking at the long-term picture, NVNO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2014.
enVVeno Medical Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VNRX (-$23M net income, -1352.2% margin), TELA (-$39M net income, -54.6% margin), NVCR (-$173M net income, -20.8% margin), NVNO has comparable earnings metrics. Compare NVNO vs VNRX →
NVNO Earnings vs Peers
Earnings metrics vs comparable public companies
NVNO Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$19M | +10.8% | -$21M | $-33.06 | - | - |
| 2024 | -$22M | +7.2% | -$24M | $-1555.75 | - | - |
| 2023 | -$24M | +4.7% | -$25M | $-2339.75 | - | - |
| 2022 | -$25M | -49.3% | -$25M | $-2695.00 | - | - |
| 2021 | -$17M | -80.9% | -$17M | $-2327.50 | - | - |
| 2020 | -$9M | -19.8% | -$9M | $-9236.50 | - | - |
| 2019 | -$8M | +41.5% | -$8M | $-14822.50 | -24406.7% | -24566.5% |
| 2018 | -$13M | -67.4% | -$8M | $-53495.75 | -6991.5% | -4210.5% |
| 2017 | -$8M | -32.4% | -$6M | $-26068.00 | -1845.8% | -1445.9% |
| 2016 | -$6M | -267.0% | -$5M | $-10412.50 | -749.0% | -592.8% |
See NVNO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVNO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVNO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVNO — Frequently Asked Questions
Quick answers to the most common questions about buying NVNO stock.
Is NVNO growing earnings?
NVNO EPS is $-28.77, with earnings growth accelerating to +97.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-19M.
What are NVNO's profit margins?
enVVeno Medical Corporation net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are NVNO's earnings?
NVNO earnings data spans 2014-2025. The accelerating earnings trend is +97.9% YoY. Historical data enables comparison across business cycles.